POMPANO, Fla., Aug. 25, 2017 /PRNewswire/ -- This past Tuesday, executive members of three Florida companies, Sincerus Florida, The Physician Dispensing Association, and Prescriber's Choice, sat down with Representative Ted Deutch to discuss responding to the challenges of delivering affordable care via physician dispensing, and solutions to promote safe, and affordable point-of-care dispensing. Congressman Deutch has been an outspoken proponent for providing and protecting affordable care in America primarily through the Patient Protection and Affordable Care Act of 2010.
Sincerus, an FDA registered 503b facility, supplies medication prepared under strict CGMP (Current Good Manufacturing Practices) guidelines. Currently, Sincerus provides safe, quality medications to healthcare providers and their patients in 34 states and growing. FDA registered 503b facilities like Sincerus are a vital link in the healthcare supply chain. 503b facilities are the only legal means for healthcare providers to obtain non-patient specific compounded medications to administer or provide to their patients.
Prescriber's Choice is a management company that helps physicians who seek to implement or expand prescription medication dispensing in their practices. The Company provides several tools and services that help physicians meet all necessary requirements to be compliant, and technology solutions to promote efficiency. Prescriber's Choice physician members work with suppliers like Sincerus to offer an expanded range of therapeutic options to their patients. All of this is done while keeping prices low, so low they often fall below what an average copay would be through a patient's insurance carrier.
These two organizations are working together with physicians across the country to disrupt the notion that medications need to be expensive and often unavailable due to cost. Much of their work has been done within the dermatology specialty that has seen prices in medications grow exponentially over the past few years. The worldwide market for prescription dermatological medications reached $23.4 billion in 2016. It has been well established that cost is becoming a barrier to treatment, while the prices of these medications continue to rise.
There are some in the healthcare industry who are refusing to accept the rising cost of medications as the norm. Companies like Sincerus and Prescriber's Choice are spearheading exciting new trends. One of these new trends is a movement towards dispensing customized prescription medications in the office. This movement not only gives patients a convenient service, it takes a tremendous financial burden off the healthcare system while increasing overall patient outcomes.
With so much negative press and headlines about price gouging in the realm of pharmaceuticals, it is truly refreshing to see companies, not only working to change these negative trends, but working together to enhance the treatment choices of physicians and their patients. Sincerus Florida and Prescriber's Choice welcomed the visit from their local congressional representative, Ted Deutch, to discuss how our leaders can assist companies like Sincerus Florida and Prescriber's Choice to reduce out of control costs, improve access to effective high-quality medications, and increase patient compliance to improve overall outcomes to the patient and the entire healthcare system.
CONTACT: Anthony Phillips, 1-347-563-0958, firstname.lastname@example.org
SOURCE Physician Dispensing Association